Shift from approvals to digital intimation via NSWS portal aims to cut timelines and boost innovation in early-stage drug development
The upcoming multi-center, multinational Phase 1 study will evaluate safety, tolerability, pharmacokinetics, and early signs of efficacy
The new test offers a minimally invasive blood-based approach to tracking neurological damage, measuring neurofilament light chain
No adverse events reported; recall involves 5 mg 500-count bottles in the US market
The FDA clearance of Zeto New Wave marks the company’s third cleared device, alongside Zeto WR19 and Zeto ONE
The approach, which could significantly reduce the number of rats used in certain dose-range finding studies
The new assay consolidates screening for four major viral threats into a single workflow
Since launching, the hospital has performed over 40 intestinal transplants, including 21 in 2025 alone
The newly classified assays join Roche’s Ionify 25-Hydroxy Vitamin D total assay in a growing U.S. portfolio
Under the agreement, healthcare professionals in the country will gain access to C2N’s PrecivityAD2 blood test
Subscribe To Our Newsletter & Stay Updated
